Mona Chitre, PharmD, CGP: Every social determinant of health has the impact and the potential to exacerbate MDD [major depressive disorder]. MDD and social determinants of health have a unique relationship. Social determinants of health can trigger mental health disorders, and mental health disorders can cause someone to make poor life decisions that trigger social determinants of health.
Let’s talk about social determinants of health. I often say it’s anything in your environment that can enable you to thrive, be well, or see a positive future. In the mental health arena, some pop up frequently. In no particular order, one is safe housing. Is there a safe housing option for our members? Are they in a safe community? Are they free of trauma and stress? Food and transportation are some basics. Do they know where their next meal is going to come from? Do they have access to a physician’s office or a pharmacy? Income level is another. Income level has many triggers toward health care disparities in general. It affects health care literacy, access to care, and access to treatment. Is their job secure? Is it a toxic environment? Is it safe? Family relationships [are another factor]. That’s just to name a few. Is there a family support group? Any social determinant of health can trigger a mental health challenge, a mental health crisis, or a mental health disorder.
Jay Weaver, PharmD, MPH: I have to agree with Dr Chitre. Most of the things she outlined were spot on. The only thing I’d add would be some of the nutritional challenges. We’re coming to understand that there’s a link between the foods that we eat and have access to and our sense of well-being. Things like high-calorie foods and high-carbohydrate foods are typically less expensive than higher-quality foods. We also know that the amounts of sugar and other things in those foods can affect our mental well-being. Sometimes food insecurity plays into major depressive disorder in ways that we don’t fully understand.
Transcript edited for clarity.
Social Determinants of Health in MDD: Part 2
Key social determinants of health impacting MDD are discussed by expert payer panelists.
EP: 1.Unmet Needs in Treatment of MDD
EP: 2.MDD Treatment Landscape
EP: 3.Potential Consequences of Recurrent or Poorly Controlled MDD
EP: 4.Burden of Treatment Failure in MDD
EP: 5.Importance of Early Effective Treatment of MDD
EP: 6.Evaluating MDD Treatment Attributes
EP: 7.Considerations for Newly Launched MDD Treatments
EP: 8.Healthcare Disparities Within Major Depressive Disorder
EP: 9.MDD Treatment Disparities Across Patient Populations
EP: 10.Social Determinants of Health in MDD
EP: 11.Impact of COVID-19 on Demand for Mental Health Services
EP: 12.Health Care Disparities Within Major Depressive Disorder (MDD)
EP: 13.MDD Treatment Disparities Across Patient Populations: Part 2
EP: 14.Social Determinants of Health in MDD: Part 2
EP: 15.Population Health Approach in MDD
EP: 16.Factors Affecting MDD Treatment Adherence
EP: 17.Supporting Adherence for Patients with MDD
EP: 18.Aligning MDD Treatment Goals for Payers and Patients
EP: 19.The Impact of Early Effective Treatment in MDD
EP: 20.Key Contributors to Long-term Outcomes for Patients With MDD
Mona Chitre, PharmD, CGP: Every social determinant of health has the impact and the potential to exacerbate MDD [major depressive disorder]. MDD and social determinants of health have a unique relationship. Social determinants of health can trigger mental health disorders, and mental health disorders can cause someone to make poor life decisions that trigger social determinants of health.
Let’s talk about social determinants of health. I often say it’s anything in your environment that can enable you to thrive, be well, or see a positive future. In the mental health arena, some pop up frequently. In no particular order, one is safe housing. Is there a safe housing option for our members? Are they in a safe community? Are they free of trauma and stress? Food and transportation are some basics. Do they know where their next meal is going to come from? Do they have access to a physician’s office or a pharmacy? Income level is another. Income level has many triggers toward health care disparities in general. It affects health care literacy, access to care, and access to treatment. Is their job secure? Is it a toxic environment? Is it safe? Family relationships [are another factor]. That’s just to name a few. Is there a family support group? Any social determinant of health can trigger a mental health challenge, a mental health crisis, or a mental health disorder.
Jay Weaver, PharmD, MPH: I have to agree with Dr Chitre. Most of the things she outlined were spot on. The only thing I’d add would be some of the nutritional challenges. We’re coming to understand that there’s a link between the foods that we eat and have access to and our sense of well-being. Things like high-calorie foods and high-carbohydrate foods are typically less expensive than higher-quality foods. We also know that the amounts of sugar and other things in those foods can affect our mental well-being. Sometimes food insecurity plays into major depressive disorder in ways that we don’t fully understand.
Transcript edited for clarity.
Patient Care Experience Declines After Private Equity Hospital Acquisitions
January 31st 2025Private equity hospital acquisitions in the US were associated with declines in patient care experience, particularly in overall hospital ratings, willingness to recommend, and staff responsiveness.
Read More
Five Years Later: Ongoing COVID-19 Challenges, Next Steps
December 23rd 2024On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.
Listen
Variable Levels of Lipoprotein Cholesterol Linked to Dementia
January 31st 2025Older adults had a higher risk of dementia if they had varied levels of lipoprotein cholesterol.
Read More
Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi
December 17th 2024Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.
Listen
Genetic Causal Link Found Between RA, Increased Fracture Risk
January 30th 2025A genetic causal link between rheumatoid arthritis (RA) and an increased risk of traumatic and osteoporotic fractures underscores the need for targeted prevention strategies.
Read More
SynKIR-310 Dosing for B-NHL Begins in CELESTIAL-301 Trial
January 30th 2025The CELESTIAL-301 trial evaluating SynKIR-310, a novel chimeric antigen receptor T-cell therapy, has dosed its first patient with relapsed/refractory B-cell non-Hodgkin lymphoma (B-NHL).
Read More
Patient Care Experience Declines After Private Equity Hospital Acquisitions
January 31st 2025Private equity hospital acquisitions in the US were associated with declines in patient care experience, particularly in overall hospital ratings, willingness to recommend, and staff responsiveness.
Read More
Five Years Later: Ongoing COVID-19 Challenges, Next Steps
December 23rd 2024On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.
Listen
Variable Levels of Lipoprotein Cholesterol Linked to Dementia
January 31st 2025Older adults had a higher risk of dementia if they had varied levels of lipoprotein cholesterol.
Read More
Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi
December 17th 2024Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.
Listen
Genetic Causal Link Found Between RA, Increased Fracture Risk
January 30th 2025A genetic causal link between rheumatoid arthritis (RA) and an increased risk of traumatic and osteoporotic fractures underscores the need for targeted prevention strategies.
Read More
SynKIR-310 Dosing for B-NHL Begins in CELESTIAL-301 Trial
January 30th 2025The CELESTIAL-301 trial evaluating SynKIR-310, a novel chimeric antigen receptor T-cell therapy, has dosed its first patient with relapsed/refractory B-cell non-Hodgkin lymphoma (B-NHL).
Read More